Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 4254.00 | 4133.00 | 1.0293 | 1.0352 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 3395.00 | 4133.00 | 0.8214 | 0.7758 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 2500.00 | 1312.79 | 4014.00 | 4133.00 | 0.9712 | 0.9650 |
| BT-20 | Erlotinib | 10 | uM | 7 | 2500.00 | 1312.79 | 2826.00 | 4133.00 | 0.6838 | 0.5895 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 2500.00 | 1312.79 | 2688.00 | 4133.00 | 0.6504 | 0.5421 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 2500.00 | 1312.79 | 3947.00 | 4133.00 | 0.9550 | 0.9451 |
| BT-20 | Lapatinib | 10 | uM | 7 | 2500.00 | 1312.79 | 1869.00 | 4133.00 | 0.4522 | 0.2380 |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 4080.00 | 4133.00 | 0.9872 | 0.9845 | |
| BT-20 | 0 | uM | 7 | 2500.00 | 1312.79 | 1.00 | 4133.00 | 0.0002 | -0.9870 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 2.00 | 7786.75 | 0.0003 | -0.9120 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7892.00 | 7786.75 | 1.0135 | 1.0102 | |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 5000.00 | 1243.75 | 7619.00 | 7786.75 | 0.9785 | 0.9836 |
| BT-20 | Linsitinib | 0.031623 | uM | 7 | 5000.00 | 1243.75 | 7678.00 | 7786.75 | 0.9860 | 0.9894 |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7318.00 | 7786.75 | 0.9398 | 0.9536 | |
| BT-20 | 17-AAG | 1 | uM | 7 | 5000.00 | 1243.75 | 2561.00 | 7786.75 | 0.3289 | 0.3138 |
| BT-20 | Linsitinib | 10 | uM | 7 | 5000.00 | 1243.75 | 6218.00 | 7786.75 | 0.7985 | 0.8370 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 5000.00 | 1243.75 | 2566.00 | 7786.75 | 0.3295 | 0.3148 |
| BT-20 | Lapatinib | 0.01 | uM | 7 | 5000.00 | 1243.75 | 7580.00 | 7786.75 | 0.9735 | 0.9798 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 5000.00 | 1243.75 | 4612.00 | 7786.75 | 0.5923 | 0.6409 |
| BT-20 | Lapatinib | 0.1 | uM | 7 | 5000.00 | 1243.75 | 7517.00 | 7786.75 | 0.9654 | 0.9735 |
| BT-20 | Lapatinib | 0.031623 | uM | 7 | 5000.00 | 1243.75 | 7829.00 | 7786.75 | 1.0054 | 1.0041 |
| BT-20 | Linsitinib | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 7401.00 | 7786.75 | 0.9505 | 0.9620 |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7814.00 | 7786.75 | 1.0035 | 1.0026 | |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 5000.00 | 1243.75 | 7521.00 | 7786.75 | 0.9659 | 0.9739 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 5000.00 | 1243.75 | 7442.00 | 7786.75 | 0.9557 | 0.9661 |